Literature DB >> 22345058

What are the current results of sutureless valves in high-risk aortic valve disease patients?

Amir H Sepehripour1, Leanne Harling, Thanos Athanasiou.   

Abstract

A best evidence topic was written according to a structured protocol. The question addressed was whether sutureless aortic valves have a clinical and haemodynamic benefit in high-risk patients with aortic valve disease. A total of 307 papers were found using the reported searches; of which, six represented the best evidence to answer the clinical question. The authors, date, journal, study type, population, main outcome measures and results are tabulated. The studies found analysed the outcomes of sutureless aortic valve implantation in high-risk patients undergoing aortic valve replacement. Reported measures included mortality; post-operative complications namely stroke, renal failure, endocarditis and bleeding; valve deployment, cardiopulmonary bypass (CPB) and aortic cross-clamp (ACC) times; echocardiographic assessment of paravalvular leaks (PVLs) and valve haemodynamics; and symptomatic functional class. Hospital mortality ranged between 3.1 and 12.5% and long-term mortality ranged between 3.1 and 10%. Incidence of PVL was found to be between 0.0 and 11%. Stroke was observed in 0.7%, renal failure in 3.1%, prosthetic valve endocarditis in 2.1-3.1% and major bleeding in 3.1%. The valve deployment time was 9-21 min, CPB time 35-111 min and ACC time 17-70 min. Short-term mean and peak valve gradients were in the ranges of 10-11 and 18-22 mmHg, respectively, reducing to 8-9 and 16.4-19 mmHg, respectively, at follow-up. Owing to the lack of comparative studies analysing the outcomes of sutureless and conventional aortic valves, we compared these results with the recently published PARTNER Trial (Transcatheter vs. Surgical Aortic-Valve Replacement in High-Risk Patients), and it can be shown that the outcomes of sutureless aortic valves compare favourably with conventional valves in terms of mortality, neurological deficit, renal failure and post-operative bleeding. However, there is increased incidence of endocarditis and PVLs, together with raised mean valve gradients, perhaps owing to the mechanical properties and deployment techniques of sutureless aortic valves.

Entities:  

Mesh:

Year:  2012        PMID: 22345058      PMCID: PMC3329292          DOI: 10.1093/icvts/ivs011

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience.

Authors:  Ingo Breitenbach; Gerhard Wimmer-Greinecker; Leo A Bockeria; Jerzy Sadowski; Christoph Schmitz; Boguslaw Kapelak; Krzysztof Bartus; Ravil Muratov; Wolfgang Harringer
Journal:  J Thorac Cardiovasc Surg       Date:  2010-08-02       Impact factor: 5.209

2.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

3.  Sutureless aortic valve replacement with the 3f Enable aortic bioprosthesis.

Authors:  Sven Martens; Anja Ploss; Sami Sirat; Alexandra Miskovic; Anton Moritz; Mirko Doss
Journal:  Ann Thorac Surg       Date:  2009-06       Impact factor: 4.330

4.  Sutureless Perceval S aortic valve replacement: a multicenter, prospective pilot trial.

Authors:  Malakh Shrestha; Thierry Folliguet; Bart Meuris; Alain Dibie; Christoph Bara; Marie-Christine Herregods; Nawid Khaladj; Christian Hagl; Willem Flameng; Francois Laborde; Axel Haverich
Journal:  J Heart Valve Dis       Date:  2009-11

5.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

6.  Clinical experience with the ATS 3f Enable® Sutureless Bioprosthesis.

Authors:  Sven Martens; Jerzy Sadowski; Friedrich S Eckstein; Krzysztof Bartus; Boguslaw Kapelak; Hans-Hinrich Sievers; Christian Schlensak; Thierry Carrel
Journal:  Eur J Cardiothorac Surg       Date:  2011-02-20       Impact factor: 4.191

7.  Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes.

Authors:  Willem Flameng; Marie-Christine Herregods; Hadewich Hermans; Gerry Van der Mieren; Monique Vercalsteren; Gert Poortmans; Jan Van Hemelrijck; Bart Meuris
Journal:  J Thorac Cardiovasc Surg       Date:  2011-04-07       Impact factor: 5.209

8.  Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis.

Authors:  Thierry Aymard; Alexander Kadner; Nazan Walpoth; Volkhart Göber; Lars Englberger; Mario Stalder; Friedrich Eckstein; Claudia Zobrist; Thierry Carrel
Journal:  J Thorac Cardiovasc Surg       Date:  2010-08       Impact factor: 5.209

  8 in total
  2 in total

Review 1.  Current status and future perspectives of prosthetic valve selection for aortic valve replacement.

Authors:  Hiroshi Furukawa; Kazuo Tanemoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-05-31

2.  Acute Kidney Injury after Heart Valve Surgery in Elderly Patients: any Risk Factors to Modify?

Authors:  Yolanda Carrascal; Gregorio Laguna; Miriam Blanco; Lucia Pañeda; Bárbara Segura
Journal:  Braz J Cardiovasc Surg       Date:  2021-02-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.